Bishop was a signatory to a letter to Mike Crapo, the chair of the Senate Banking Committee on Thursday, thanking him for proposing a series of restrictive changes to a House-passed bill to provide marijuana businesses with greater access to financial services.
Holds office U.S. House District 9
In response to 2018 NC Family Policy Council question, "Should NC legalize the use of marijuana for medical purposes?" Bishop responded NO with the note "Except in non-inhaled, pill form"
Response to 2020 NC Family Policy Council's question "Should Congress legalize the use of marijuana for medical purposes?" NO with the note "extract or pills fine"
A 'D' letter grade indicates that this candidate has expressed no support for any significant marijuana law reform, though they may have cosponsored/voted for legislation for minor reform (CBD/hemp).
Bishop served in the NC House from 2015-2017 and the NC Senate from 2017-2019 when he was elected to Congress in a special election.
As a Representative:
Excused Absence on HB766-Amend CBD Oil Statute which proposed that board certified neurologists may recommend hemp extract containing less than 0.9% THC by weight and at least 5% cannabidiol by weight to patients with intractable epilepsy without enrolling in pilot studies, and that DHHS set up a database of patients, caregivers and neurologists rather than a registry. 2015
Voted Aye on SB313-Industrial Hemp which proposed the development of an industrial hemp industry in the State in order to expand employment, promote economic activity, and provide opportunities to small farmers for an environmentally sustainable and profitable use of crop lands that might otherwise be lost to agricultural production; to establish an agricultural pilot program for the cultivation of industrial hemp in the State, to provide for reporting on the program by growers and processors for agricultural or other research, and to pursue any federal permits or waivers necessary to allow industrial hemp to be grown in the State. 2015
Voted Aye on HB992/SB77-Amend Industrial Hemp Definition which proposed modifications in language of SL2015-299, increased number of Commissioners from 5 to 9, proposed that the Commission will issue licenses for “research” to include “the growth, cultivation, and marketing of industrial hemp.” 2016
As a Senator:
Voted Aye on SB124-LEO Managed CBD Oil Drop Box which proposed that any individual who possesses or uses hemp extract, as defined under this section, shall dispose of all residual oil from the extract at a secure collection box managed by a law enforcement agency, and that any neurologist who approves of dispensing hemp extract to a registered caregiver, shall inform the registered caregiver that disposal must be done at a secure collection box. 2018
Voted Aye on SB168-Expand Allowed Medical Uses/Cannabis Extract which adds to the proposed changes to GS 90-94.1 to also allow the possession or use of cannabis extract to treat a medical condition diagnosed by a neurologist for which currently available treatment options have been ineffective (was only expanded to treat autism, multiple sclerosis, Crohn's disease, or Mitochondrial disease, in addition to the already allowable treatment of intractable epilepsy). Makes conforming modifications to the proposed changes to Article 5G, GS Chapter 90, Alternative Treatment Act, to include patients who have been diagnosed with a medical condition for which currently available treatment options have been ineffective. 2019
1207 Longworth House Office Building
Washington, DC 20515